
Sterling Pharma Solutions Ltd.
Sterling Pharma Solutions Ltd.
2 Projects, page 1 of 1
assignment_turned_in Project2019 - 2023Partners:AstraZeneca plc, Sterling Pharma Solutions Ltd., Concept Life Sciences (United Kingdom), Dr Reddy's Laboratories UK Ltd, AstraZeneca (United Kingdom) +10 partnersAstraZeneca plc,Sterling Pharma Solutions Ltd.,Concept Life Sciences (United Kingdom),Dr Reddy's Laboratories UK Ltd,AstraZeneca (United Kingdom),Asynt,University of Leeds,Asynt,Sterling Pharma Solutions Ltd.,ASTRAZENECA UK LIMITED,Dr. Reddy's Laboratories (United Kingdom),Concept Life Sciences,Imperial College London,University of Leeds,Concept Life SciencesFunder: UK Research and Innovation Project Code: EP/S013768/1Funder Contribution: 871,781 GBPThis project aims to deliver the underpinning tools and design principles to support the use of water as a reaction media in High Value Chemical Manufacture. Water has long been promoted as an environmentally friendly and safe 'green' reaction media for synthetic processes which can lead to much more sustainable and cost effective manufacturing process. Nevertheless, the green credential of water has been limited due to issues related to organic contamination of the water waste stream, cost of subsequent treatment and the often required organic solvents at purification stage. Water-accelerated reactions, i.e. reactions which proceed faster in water than in organic solvents and wherein organic reactants and products form hydrophobic droplets, are potential game-changers High Value Chemical Manufacture. They benefit from accelerated rates, improved productivity and much improved green metrics through reduction in the use of organic solvents. Their current limitations are: (i) a limited pool of known reactions; (ii) lack of suitable equipment and process understanding; and (iii) insufficient understanding of acceleration effects which can guide discovery and process design. This project will address these knowledge gaps and deliver the following critical outputs, identified through discussion with our industrial partners in chemical industry sector: (i) a wider range of synthetically useful water-accelerated reactions, (ii) multi-scale batch and flow reactors to support the scale-up pathway for water-accelerated processes, (iii) standardised protocols for characterising such processes and basic process understanding for scaling up, and (iv) streamlined workup/product purification and recycling of water to truly deliver green processes. These outputs will have transformative impacts in the chemical manufacture industry, delivering lower cost and better quality controlled processes through shorter routes, reduced organic waste and facile interfacing between chemo- and biocatalytic processes.
All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::fdb575199c0f323599446931f8c88ca1&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eumore_vert All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::fdb575199c0f323599446931f8c88ca1&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.euassignment_turned_in Project2019 - 2027Partners:Croda International Plc, University of Leeds, Pfizer, Britest Limited, Infineum (United Kingdom) +50 partnersCroda International Plc,University of Leeds,Pfizer,Britest Limited,Infineum (United Kingdom),Innospec (United Kingdom),BRITEST Ltd,University of Queensland,UK-CPI,AstraZeneca (United Kingdom),Syngenta Ltd,Syngenta (United Kingdom),Swagelok Manchester,University of Graz,South Uni of Sci and Tech of China SUST,University of Queensland,University of North Dakota,Universidade Estadual de Campinas,PROCTER & GAMBLE TECHNICAL CENTRES LIMITED,ASTRAZENECA UK LIMITED,Perceptive Engineering Limited,Venator,Diamond Light Source,Max Planck Institutes,Swagelok Manchester,Perceptive Engineering Limited,Cambridge Crystallographic Data Centre,Innospec Environmental Ltd,Infineum UK,State University of Campinas,Campinas State University,Procter & Gamble Limited (P&G UK),University of North Dakota,Xeros Ltd,University of Leeds,Biome Technologies,Graz University,SouthernUniversity of Science&Technology,Innospec Environmental Ltd,Pfizer (United States),Biome Technologies (United Kingdom),UK-CPI (dup'e),Keracol Limited,,Venator,University of Queensland,AstraZeneca plc,Sterling Pharma Solutions Ltd.,Diamond Light Source,Max-Planck-Gymnasium,Xeros Technologies (United Kingdom),Croda (United Kingdom),CRODA INTERNATIONAL PLC,CCDC,Sterling Pharma Solutions Ltd.,Keracol (United Kingdom)Funder: UK Research and Innovation Project Code: EP/S022473/1Funder Contribution: 5,345,840 GBPThe CDT in Molecules to Product addresses an overarching concern articulated by industry operating in the area of complex chemical products. It centres on the lack of a pipeline of doctoral graduates who understand the cross-scale issues that need to be addressed within the chemicals continuum. Translating their concern into a vision, the focus of the CDT is to train a new generation of research leaders with the skills and expertise to navigate the journey from a selected molecule or molecular system through to the final product that delivers the desired structure and required performance. To address this vision, three inter-related Themes form the foundation of the CDT - Product Functionalisation and Performance, Product Characterisation, and Process Modelling between Scales. More specifically, industry has identified a real need to recruit PGR graduates with the interdisciplinary skills covered by the CDT research and training programme. As future leaders they will be instrumental in delivering enhanced process and product understanding, and hence the manufacture of a desired end effect such as taste, dissolution or stability. For example, if industry is better informed regarding the effect of the manufacturing process on existing products, can the process be made more efficient and cost effective through identifying what changes can be made to the current process? Alternatively, if there is an enhanced understanding of the effect of raw materials, could stages in the process be removed, i.e. are some stages simply historical and not needed. For radically new products that have been developed, is it possible through characterisation techniques to understand (i) the role/effect of each component/raw material on the final product; and (ii) how the product structure is impacted by the process conditions both chemical and mechanical? Finally, can predictive models be developed to realise effective scale up? Such a focus will assist industry to mitigate against wasted development time and costs allowing them to focus on products and processes where the risk of failure is reduced. Although the ethos of the CDT embraces a wide range of sectors, it will focus primarily on companies within speciality chemicals, home and personal care, fast moving consumer goods, food and beverage, and pharma/biopharma sectors. The focus of the CDT is not singular to technical challenges: a core element will be to incorporate the concept of 'Education for Innovation' as described in The Royal Academy of Engineering Report, 'Educating engineers to drive the innovation economy'. This will be facilitated through the inclusion of innovation and enterprise as key strands within the research training programme. Through the combination of technical, entrepreneurial and business skills, the PGR students will have a unique set of skills that will set them apart from their peers and ultimately become the next generation of leaders in industry/academia. The training and research agendas are dependent on strong engagement with multi-national companies, SMEs, start-ups and stakeholders. Core input includes the offering, and supervision of research projects; hosting of students on site for a minimum period of 3 months; the provision of mentoring to students; engagement with the training through the shaping and delivery of modules and the provision of in-house courses. Additional to this will be, where relevant, access to materials and products that form the basis of projects, the provision of software, access to on-site equipment and the loan of equipment. In summary, the vision underpinning the CDT is too big and complex to be tackled through individual PhD projects - it is only through bringing academia and industry together from across multiple disciplines that a solution will be achievable. The CDT structure is the only route to addressing the overarching vision in a structured manner to realise delivery of the new approach to product development.
All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::42d7cef2da816a5b8b46cf0cab8023e6&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eumore_vert All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::42d7cef2da816a5b8b46cf0cab8023e6&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eu